Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
06/2012
06/28/2012US20120164153 Monoclonal antibodies against glycoprotein of ebola sudan boniface virus
06/28/2012US20120164140 Hemojuvelin fusion proteins and uses thereof
06/28/2012US20120164118 Cocal vesiculovirus envelope pseudotyped retroviral vectors
06/28/2012US20120164108 Virus strains
06/28/2012US20120164072 Nano-sized particles comprising multi-headed amphiphiles for targeted drug delivery
06/28/2012CA2822559A1 Therapeutic strategies to treat cns pathology in mucopolysaccharidoses
06/27/2012EP2468868A1 Chemotherapeutic sensitizers
06/27/2012EP2468865A1 Antisense oligonucleotide modulation of stat3 expression
06/27/2012EP2468861A1 Method of constructing gene transport support
06/27/2012EP2468299A2 Compositions for inducing immune responses
06/27/2012EP2467482A2 Treatment of 'c terminus of hsp70-interacting protein' (chip) related diseases by inhibition of natural antisense transcript to chip
06/27/2012EP2467167A1 Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeutics
06/27/2012EP1988163B1 Hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same
06/27/2012CN1878566B Multi-antigen vectors of melanoma
06/27/2012CN102517332A EGF (epidermal growth factor)-modified PAMAM (polyamidoamine) self-assembled composite for transgenosis as well as preparation method and applications thereof
06/27/2012CN102517312A Recombination ubiquitin ligase SH2-U-box fusion gene as well as expression vectors and applications thereof
06/27/2012CN102517308A Construction and application of recombinant plasmid containing chitinase gene of apple leaf miner
06/27/2012CN102517292A Immunostimulatory oligoribonucleotides
06/27/2012CN102517287A Short hairpin ribonucleic acid (shRNA) for inhibiting expression of buffalo triggering receptor expressed on myeloid cells 1 (TREM1) gene, lentiviral expression vector of shRNA and construction method and application of lentiviral expression vector
06/27/2012CN102517283A Special short hairpin ribonucleic acid (shRNA) for reducing human IQGAP1 gene expression and application thereof
06/27/2012CN102517228A Bacillus thuringiensis ST7 and anticancer gene and application thereof
06/27/2012CN102516552A Degradable acid-sensitive macromolecular amphipathic cationic block copolymers and micellar particles and preparation method thereof
06/27/2012CN102516395A Polypeptide carrier used for improving targeting ability and transfection efficiency of medicine/gene, and purpose thereof
06/27/2012CN102516394A CMG 2mutant and Fc fusion protein, its encoding gene and its application
06/27/2012CN102516393A Insulin mimetic peptide fusion protein, mutant and applications thereof
06/27/2012CN102516382A Antimicrobial peptide Hainanenin-5 of Amolops hainanensis, gene of antimicrobial peptide Hainanenin-5 of Amolops hainanensis, separation and purification method and chemical synthesis method for antimicrobial peptide Hainanenin-5 of Amolops hainanensis and application of gene of antimicrobial peptide Hainanenin-5 of Amolops hainanensis
06/27/2012CN102516356A Epitope polypeptide applicable to mycobacterium tuberculosis infection detection and application thereof
06/27/2012CN102512694A Biological preparation for resisting against replication and infection of foot-and-mouth disease virus and preparation method as well as application thereof
06/27/2012CN102512693A Preparation method of porcine epidemic diarrhea recombinant adenovirus vaccine
06/27/2012CN102512689A Carrier composition for nucleic acid transport
06/27/2012CN102512683A Polymer gene medicine carrier, preparation method thereof and use thereof for preparing antitumor medicine
06/27/2012CN102512661A Protein containing 1st to 79th sites of amino acid basic sequences in protein 2C of coxsackievirus B3 and application for same
06/27/2012CN102512660A Protein containing 51st to 89th sites of amino acid basic sequences in protein 3A of coxsackievirus B3 and application for same
06/27/2012CN102220324B SiRNA for inhibiting gene expression of caspase-3
06/27/2012CN101966341B Adenovirus/viruses A replicon chimeric vector hogcholeravaccine and application thereof
06/27/2012CN101880397B Cross linking polymer and preparation method thereof
06/27/2012CN101879317B Preparation method and application of Vibro harveyi and Vibrio parahaemolyticus bigeminy DNA vaccine
06/27/2012CN101838650B Development and applications of new human gene FAMLF in human gene recombination, malignant tumor gene detection and specific monoclonal antibody
06/27/2012CN101481421B Recombinant antigen polypeptide for treating Alzheimer's disease and polypeptide gene
06/27/2012CN101291653B Lipid encapsulated interfering rna
06/26/2012USRE43497 Anti-MIF antibodies
06/26/2012US8207326 Identification of novel genes coding for small temporal RNAs
06/26/2012US8207314 Tumor antigens for prevention and/or treatment of cancer
06/26/2012US8207142 Inhibitor of DNA methylation
06/26/2012US8207141 Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof
06/26/2012US8207140 Oligomeric compounds for the modulation of HIF-1α expression
06/26/2012US8207139 Function of GPR4 in vascular inflammatory response to acidosis and related methods
06/26/2012US8207137 administering a therapeutically effective amount of an active agent selected from the group consisting of a protein substance including all or part of a disintegrin domain of an adamalysin or a derivative thereof
06/26/2012US8207123 Tumour-specific animal proteins
06/26/2012US8206965 Single-chain rare-cutting endonucleases; for genetic engineering and gene therapy
06/26/2012US8206931 Methods of identifying modulators of cellular glycosylation using GTRAP3-18
06/26/2012US8206743 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
06/26/2012US8206718 Expression and export of angiogenesis inhibitors as immunofusins
06/26/2012US8206708 Vascular endothelial growth factor 2
06/26/2012US8206701 Human leukocyte antigen (HLA); into which proteins and/or peptides or RNA or DNA or cDNA encoding the proteins and/or peptides which are overexpressed in tumor cells or which are derived from tumor cells have been introduced
06/26/2012CA2605629C Nipah virus vaccines
06/26/2012CA2406853C Methods and compositions for eliciting an immune response
06/26/2012CA2382832C Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna
06/26/2012CA2237316C Complex cationic lipids
06/21/2012WO2012083024A1 Treatment of spinal cord injury and traumatic brain injury using placental stem cells
06/21/2012WO2012083023A1 Treatment of spinal cord injury and traumatic brain injury using amnion derived adherent cells
06/21/2012WO2012082574A1 Membrane lytic poly(amido amine) polymers for the delivery of oligonucleotides
06/21/2012WO2012082470A2 The use anti-cxcl16 and anti-cxcr6 antibodies for the treatment or detecting cancer
06/21/2012WO2012081799A1 Polynucleotide delivering complex for target cell
06/21/2012WO2012047956A3 Treatment of sialidase 4 (neu4) related diseases by inhibition of natural antisense transcript to neu4
06/21/2012WO2012037078A3 Immunogenic respiratory syncytial virus glycoprotein-containing vlps and related compositions, constructs, and therapeutic methods
06/21/2012WO2012027555A3 Glycated cd59 peptides, their preparation, and uses thereof
06/21/2012WO2011090741A9 TREATMENT OF TUMOR PROTEIN 63 (p63) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO p63
06/21/2012US20120159659 Custom-made meganuclease and use thereof
06/21/2012US20120157514 Oligomeric compounds and compositions for use in modulation of small non-coding rnas
06/21/2012US20120156231 Foxm1 peptides and vaccines containing the same
06/21/2012US20120156180 Compositions and methods for the treatment of krabbe and other neurodegenerative diseases
06/21/2012US20120156170 Drug composition for angiogenesis therapy
06/20/2012EP2465931A1 Light-receiving channel rhodopsin having improved expression efficiency
06/20/2012EP2465538A2 Use of immunesuppressant receptor
06/20/2012EP2465520A2 Epitope sequences
06/20/2012EP2464731A2 Treatment of adiponectin (adipoq) related diseases by inhibition of natural antisense transcript to an adiponectin (adipoq)
06/20/2012EP2464385A2 Photochemical internalization method
06/20/2012EP2464384A2 Photosensitizing compositions
06/20/2012EP2464377A1 Use of il-15 to increase thymic output and to treat lymphopenia
06/20/2012EP2464336A2 Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus
06/20/2012EP1252182B1 PROTEINS COMPRISING CONSERVED REGIONS OF NEISSERIA MENINGITIDIS SURFACE ANTIGEN NhhA
06/20/2012CN1942201B Methods of modulating cytokine activity, related reagents
06/20/2012CN102505022A RNA interference vector capable of simultaneously silencing multiple ligands of NKG2D, and construction method and application thereof
06/20/2012CN102505014A Trichinella spiralis muscle larva microRNA and application thereof
06/20/2012CN102504280A Method for preparing biofilm-imitated vesicle structure by utilizing modified hyper-branched polymer
06/20/2012CN102504015A Cardiovascular targeted small peptide MI-1 and application thereof
06/20/2012CN102499996A Fibrous membrane for non-virus gene treatment and preparation method thereof
06/20/2012CN102499987A Application of miR-1 in production of preparation for treating primary glaucoma
06/20/2012CN102002499B shRNA capable of inhibiting replication and infection of Japanese encephalitis virus and application thereof
06/20/2012CN101935656B Gene for promoting insulin secretion, preparation method and application thereof
06/20/2012CN101892255B Recombinant vector for regulating expression of two target genes by using promoter
06/20/2012CN101768576B HSV1-TK (herpes simplex virus type 1-thymidine kinase) gene recombination oncolytic adenovirus, preparation method and application thereof
06/19/2012US8202981 Compositions and their uses directed to PTPRU
06/19/2012US8202980 Antisense oligonucleotide for use in prevention and treatment of viral and tumor disorders; gene expression inhibition; RNA interference
06/19/2012US8202979 siNA molecule comprising a double-stranded structure that down-regulates expression of a target nucleic acid, wherein said siNA molecule does not require a 2'-hydroxyl group containing ribonucleotide; treating viral diseases such as SARS (severe acute respiratory syndrome virus), herpes, hepatitis, HIV
06/19/2012US8202849 Methods and compositions for the inhibition of Stat5 in prostate cancer cells
06/19/2012US8202848 Identification of micro-RNAS involved in neuromuscular synapse maintenance and regeneration
06/19/2012US8202847 Mutant human CD80 and compositions for and methods of making and using the same
06/19/2012US8202846 Methods and compositions for RNA interference
1 ... 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 ... 870